Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "gut microbiota and immune system" describes the complex, dynamic interplay between the diverse microbial community inhabiting the gastrointestinal tract and the host's innate and adaptive immune systems. This axis regulates immune responses, maintains mucosal and barrier integrity, modulates inflammation, and impacts systemic metabolic and disease processes. Key mechanisms include direct microbial signaling to immune cells, production of metabolites (such as short-chain fatty acids) that modulate immune function, regulation of immunoglobulin (IgA, IgG) production, and maintenance of tolerance to commensals while defending against pathogens. Disruption of this balance ("dysbiosis") is implicated in a wide range of diseases, including inflammatory, autoimmune, metabolic, and malignant conditions.
Enhancement of beneficial bacteria to modulate immune responses; Suppression of pathogenic bacteria to reduce inflammation; Modulation of microbial metabolites (e.g., butyrate) that directly affect immune cells; Stimulation of barrier defenses (barrier effect).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota and immune system.